{"id":"W2120711586","doi":"10.1016/s1470-2045(14)70005-1","title":"Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 study","year":2014,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Rituximab; Follicular lymphoma; Clinical endpoint; Internal medicine; International Prognostic Index; Vincristine; Regimen; Prednisone; Cyclophosphamide; Population; Lymphoma; Oncology; Gastroenterology; Surgery; Randomized controlled trial; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003219124,0.001477813,0.002998566,0.0004777504,0.0004520201,0.001563335,0.00104189,0.0017694,0.004119496],"category_scores_gemma":[0.003192653,0.001042901,0.0031012,0.000590707,0.001714712,0.00152098,0.0004554007,0.00338806,0.0009254382],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001697297,"about_ca_system_score_gemma":0.001692597,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001412589,"about_ca_topic_score_gemma":0.001949614,"domain_scores_codex":[0.9978042,0.001489027,0.0000765053,0.0002409854,0.0001622174,0.000227046],"domain_scores_gemma":[0.9974641,0.0008287373,0.0007043508,0.0003665745,0.0001285322,0.0005076612],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9694906,0.003683517,0.001752301,0.000240149,0.001426156,0.00004122528,0.0001125944,0.0008119125,0.004416205,0.00008409057,0.0004689507,0.01747216],"study_design_scores_gemma":[0.8498524,0.1376717,0.008428077,0.00002824953,0.001163091,0.00009555245,0.00004017577,0.0007657461,0.000919327,0.0002420856,0.0007528652,0.00004085681],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955816,0.00183765,0.0004532336,0.0002026863,0.00007047479,0.0006572868,0.0004487585,0.00006333577,0.0006850196],"genre_scores_gemma":[0.9958847,0.000852622,0.0006709811,0.0003519146,0.0001040011,0.000680099,0.0005482895,0.00003739168,0.0008700167],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004119496,"threshold_uncertainty_score":0.01702458,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02571659792626668,"score_gpt":0.3512134032239786,"score_spread":0.325496805297712,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}